Breakthroughs in Brain Cancer
Thanks to your regular gift, we can continue to learn more about, and hopefully reduce, the most aggressive form of brain cancer in the world.
Your Impact in Action
As you know, the government only funds 11-13% of ALL cancer research.
So, at Chris O’Brien Lifehouse, we rely on the generosity of donors like you to support our ongoing research like that which Dr. Kaufman is conducting.
Dr. Kaufman and her team have already made an incredibly exciting discovery – they have identified a blood biomarker (a predictor) for glioblastoma.
This means they can develop a blood test to see the progression of an individual’s tumour and the response to treatment. It also will mean reducing unnecessary neurosurgeries and better managing treatments and quality of life.
Alongside the research into the blood marker, Dr. Kaufman’s team are working on a data registry program known as GlioNET, to track all Australians with glioblastoma multiforme – from first diagnosis throughout the entire course of their illness and treatment.
Once established, the registry will eventually be rolled out to all major hospitals across Australia. With this in place, a unique, open-access platform for critical research into brain cancer will be available to help the thousands of Australians diagnosed with brain cancer every year.
Without support from donors like you, this research and this registry would not be possible.
Thank you on behalf of everyone at Chris O’Brien Lifehouse – you are helping us transform lives and give people the best treatment possible.
Learn more about the other more research your ongoing support is helping fund at Chris O’Brien Lifehouse.